Full Text View
Tabular View
No Study Results Posted
Related Studies
Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1
This study is ongoing, but not recruiting participants.
Study NCT00033072   Information provided by National Institute on Drug Abuse (NIDA)
First Received: April 5, 2002   Last Updated: October 23, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Amphetamine-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Selegiline
Additional drug interventions recognized in this trial
Amphetamine
Methamphetamine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Anti-Dyskinesia Agents
Antiparkinson Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Monoamine Oxidase Inhibitors
Neuroprotective Agents
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services